Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonDividends Paid - PreferredFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Depreciation and Depletion: 2009-2025

Historic Depreciation and Depletion for Amdocs (DOX) over the last 15 years, with Sep 2025 value amounting to $1.0 billion.

  • Amdocs' Depreciation and Depletion fell 11.61% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 13.14%. This contributed to the annual value of $128.8 million for FY2025, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Amdocs' Depreciation and Depletion stood at $1.0 billion, which was up 8.03% from $942.0 million recorded in Q2 2025.
  • In the past 5 years, Amdocs' Depreciation and Depletion ranged from a high of $1.2 billion in Q3 2024 and a low of $899.5 million during Q1 2021.
  • Over the past 3 years, Amdocs' median Depreciation and Depletion value was $1.1 billion (recorded in 2023), while the average stood at $1.0 billion.
  • In the last 5 years, Amdocs' Depreciation and Depletion increased by 10.94% in 2023 and then declined by 14.65% in 2025.
  • Amdocs' Depreciation and Depletion (Quarterly) stood at $944.5 million in 2021, then rose by 9.65% to $1.0 billion in 2022, then rose by 2.44% to $1.1 billion in 2023, then decreased by 14.11% to $911.2 million in 2024, then decreased by 11.61% to $1.0 billion in 2025.
  • Its Depreciation and Depletion was $1.0 billion in Q3 2025, compared to $942.0 million in Q2 2025 and $930.5 million in Q1 2025.